Cefuroxime Surgical Prophylaxis Dosing
Standard Dose Recommendation
For most surgical procedures, administer cefuroxime 1.5 g IV as a single dose within 30-60 minutes before surgical incision, with re-dosing of 0.75 g every 2 hours intraoperatively if the procedure is prolonged. 1
Procedure-Specific Dosing
Cardiac Surgery
- Initial dose: 1.5 g IV plus 0.75 g in the CPB priming solution 1
- Intraoperative re-injection: 0.75 g every 2 hours during the procedure 1
- Alternative cardiac surgery protocol: 1.5 g IV at induction of anesthesia, then every 12 hours for a total of 6 grams 2
Vascular Surgery (Aorta, Lower Limb Arteries, Supra-aortic Trunks)
- Initial dose: 1.5 g IV slow infusion 1
- Re-injection: 0.75 g if procedure duration exceeds 2 hours 1
- Single dose only for arterial endoprosthesis and carotid surgery with patch 1
Cataract Surgery
- Intracameral injection: 1 mg in 0.1 mL at the end of the procedure 1
- This represents a unique route and dose specific to ophthalmology 1
General Clean-Contaminated or Potentially Contaminated Procedures
- Initial dose: 1.5 g IV administered one-half to 1 hour before initial incision 2
- Prolonged procedures: 750 mg IV or IM every 8 hours 2
Critical Timing Considerations
- Optimal administration window: 30-60 minutes before incision to ensure adequate tissue concentrations at the time of potential contamination 1, 3
- Maximum acceptable timing: Infusion must be completed no later than the beginning of the intervention 1
- Do not administer too early: Giving prophylaxis more than 120 minutes before incision is unnecessary and potentially dangerous 3
Intraoperative Re-dosing Guidelines
- Re-dose when: Surgical duration exceeds 2 hours (approximately two half-lives of cefuroxime) 1, 3
- Re-dosing amount: 0.75 g IV 1
- Cardiac surgery exception: Re-inject 0.75 g every 2 hours intraoperatively 1
Duration of Prophylaxis
- Standard duration: Single preoperative dose is adequate for most procedures 3
- Maximum duration: Should not exceed 24 hours postoperatively 4, 3
- Cardiac surgery exception: May continue up to 6 grams total over multiple doses 2
- Important caveat: Postoperative doses beyond the operative period provide no additional benefit and increase antibiotic resistance risk 3
Special Populations
Renal Impairment
- Creatinine clearance >20 mL/min: 750 mg to 1.5 g every 8 hours 2
- Creatinine clearance 10-20 mL/min: 750 mg every 12 hours 2
- Creatinine clearance <10 mL/min: 750 mg every 24 hours 2
- Hemodialysis patients: Give an additional dose at the end of dialysis 2
Pediatric Patients (>3 Months)
- Standard dose: 50-100 mg/kg/day divided every 6-8 hours 2
- Severe infections: 100 mg/kg/day (not exceeding maximum adult dosage) 2
- Bone and joint infections: 150 mg/kg/day divided every 8 hours (not exceeding maximum adult dosage) 2
- Pediatric cardiac surgery: 25 mg/kg pre-CPB is sufficient; a second dose in the CPB prime solution provides no additional advantage 5
Morbidly Obese Patients
- Standard 1.5 g dose distributes adequately into interstitial fluid of muscle and subcutaneous adipose tissue 6
- Important limitation: Concentrations may be sufficient for Gram-positive organisms but potentially insufficient for Gram-negative organisms 6
- Obese patients ≥120 kg: May require higher doses to achieve adequate tissue concentrations 3
Pharmacokinetic/Pharmacodynamic Targets
Coverage for Staphylococcus aureus
- Target: Unbound plasma concentrations of 2-8 mg/L 7, 8
- Standard dosing (1.5 g every 2.5 hours) achieves this target in most patients 7
Coverage for Escherichia coli
- Target: Unbound plasma concentrations of 8-32 mg/L 7, 8
- Standard dosing is insufficient for E. coli coverage in >50% of patients 7
- Optimized regimen for E. coli: 1.5 g bolus followed by continuous infusion of 3 g over 3 hours 7
- Alternative: Continuous infusion of 1 g/hour after a 1 g bolus achieves concentrations up to 32 mg/L 8
Clinical Caveats and Pitfalls
Common Errors to Avoid
- Do not continue prophylaxis beyond 24 hours unless specifically indicated (certain cardiac/vascular procedures), as this increases resistance without benefit 3
- Do not use inadequate dosing in obese patients, as tissue penetration may be compromised 3, 6
- Do not administer too early (>120 minutes before incision) 3
High-Risk Situations Requiring Prophylaxis
- Nasal surgery: Use 1.5 g IV cefuroxime if preoperative crusting, purulent secretion, or Staphylococcus aureus colonization is present 9
- Prolonged procedures: These significantly increase infection risk and require re-dosing 9